Actinium Pharmaceuticals reported $36.47M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
AbbVie USD 6.57B 2.82B Jun/2026
Actinium Pharmaceuticals USD 36.47M 5.66M Jun/2026
Amgen USD 13.99B 1.95B Jun/2026
Bioline Rx USD 2.5M 5.41M Mar/2026
Capricor Therapeutics USD 20.94M 84.49M Jun/2026
Pfizer USD 976M 727M Jun/2026